QL
SRPT icon

Quarry LP’s Sarepta Therapeutics SRPT Stock Holding History

Quarry LP’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.43K Buy
+191
New +$3.61K ﹤0.01% 1293
2025
Q4 		– Sell
-2,914
Closed -$56.2K – 2587
2025
Q3 		$56.2K Buy
+2,914
New +$51.9K 0.01% 778
2024
Q1 		– Sell
-250
Closed -$24.1K – 1889
2023
Q4 		$24.1K Buy
+250
New +$24K ﹤0.01% 655

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Quarry LP's SRPT Position: Q2 2026 in Review

Quarry LP opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 191 shares worth $3.43K. The stake represents ﹤0.01% of the portfolio and ranks #1293 among its holdings. This is a return to the name: Quarry LP previously reported a position in SRPT as recently as Q3 2025.

Quarry LP first reported a position in SRPT in Q4 2023 and has held it in 3 quarters since. The position peaked at $56.2K in Q3 2025. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Quarry LP held 191 shares of Sarepta Therapeutics worth $3.43K as of Q2 2026.
  • Sarepta Therapeutics was a new Quarry LP position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1293 holding.
  • Quarry LP first reported a position in Sarepta Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Quarry LP's Sarepta Therapeutics position peaked at $56.2K in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.